Clinical Trials in Colorado

Showing 5401-5420 of 18,143 trials

NAP in Combination With Docetaxel Following Obinutuzumab Pretreatment in Subjects With Checkpoint Inhibitor Pretreated Advanced or Metastatic NSCLC

NCT04880863

Phase 2a Open-Label, Multicenter Trial of Naptumomab Estafenatox (NAP), following Obinutuzumab Pretreatment, on Days -13 and -12. NAP will be administered on Days 1-4 of treatment cycles 1-6, followed by docetaxel on Day 5. Starting cycle 7, NAP at a higher dose will be administered on Day 1 only and docetaxel on Day 2, in 21 days treatment cycles. When NAP is administered as monotherapy and not earlier than cycle 7, NAP will be administered on Day 1 only and cycles will be of 28 days treatment cycle.

Non-small Cell Lung Cancer

NeoTX Therapeutics Ltd.38 participantsStarted Oct 2021

Daphne, Alabama, United States • Scottsdale, Arizona, United States • Tucson, Arizona, United States +8 more locations

COMPLETEDPhase 241 miles

Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn's Disease

NCT00102921

The purpose of this research study is to investigate the effects of an investigational medication, called CCX282-B, on safety and on the some of the symptoms of Crohn's Disease in patients who are experiencing an active flare-up of moderate to severe Crohn's Disease.

Crohn Disease

Amgen70 participantsStarted Aug 2004

Los Angeles, California, United States • Golden, Colorado, United States • Littleton, Colorado, United States +11 more locations

NAP in Combination With Docetaxel Following Obinutuzumab Pretreatment in Subjects With Checkpoint Inhibitor Pretreated Advanced or Metastatic NSCLC

Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn's Disease

Find Trials by Condition in Colorado

SCS as an Option for Chronic Low Back and/or Leg Pain Instead of Surgery

Information Visualizations to Enhance HIV-related Communication

A Study to Test the Effect of Different Doses of BI 1358894 and Quetiapine in People With Depression

Sodium Fluorescein-Guided Resection of Pediatric Neurosurgical Tumors

Femur Fracture: Functional Bracing vs. Hip Spica Cast

A Study to Evaluate the Anti-inflammatory Effects of Letermovir (Prevymis) in Adults With Human Immunodeficiency Virus (HIV)-1 and Asymptomatic Cytomegalovirus (CMV) Who Are on Suppressive Antiretroviral Therapy, Plus Its Effect on Chronic Inflammation, HIV Persistence and Other Clinical Outcomes.

Study to Assess the Safety and Immunogenicity of GSK Meningococcal Group B Vaccine When Administered Concomitantly With GSK Meningococcal MenACWY Conjugate Vaccine in Healthy Subjects of 16-18 Years of Age

MGD019 DART® Protein in Unresectable/Metastatic Cancer

Phase 2a to Evaluate PL-8177 in Subjects with Active Ulcerative Colitis (UC)

Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder

Effect of Extraneal (Icodextrin)on Triglyceride Levels in PD Patients

Screening Protocol for Tumor Antigen Expression Profiling and HLA Typing for Eligibility Determination

A Study to Evaluate Safety and Effectiveness of G-POEM for Gastroparesis

A Study of Increasing Strengths, Safety and Efficacy of Two Formulas of LEO 43204 on the Face or the Chest in Patients With Actinic Keratosis

Study of EYP-1901 in Patients With Diabetic Macular Edema (DME)

ViBone in Cervical and Lumbar Spine Fusion

Study of Lanreotide Autogel in Non-functioning Entero-pancreatic Endocrine Tumours

Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS)